AstraZeneca Tagrisso gets approval in Japan for early-stage lung cancer subtype

Retrieved on: 2022-08-25 08:41:56

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Tagrisso gets approval in Japan for early-stage lung cancer subtype. View article details on hiswai:

Excerpt

The Japanese Ministry of Health, Labour, and Welfare approved AstraZeneca's (AZN) Tagrisso as an adjuvant therapy for patients with epidermal ...

Article found on: seekingalpha.com